New apalutamide study opens for prostate cancer

February 14, 2018

A new phase 3 study at Providence Cancer Institute will compare the effectiveness of three different treatment regimens in men with biochemically recurrent prostate cancer:

Experimental arm: apalutamide, an investigational, next-generation oral androgen receptor (AR) inhibitor, plus degarelix, a hormonal therapy used to reduce testosterone
Experimental arm: apalutamide and degarelix plus abiraterone acetate and prednisone
Control arm: degarelix alone

“Apalutamide (ARN-509) reduced the risk of metastasis or death by 72% in patients with nonmetastatic castration-resistant prostate cancer,” according to findings from the phase 3 SPARTAN trial reported in OncLive on Feb. 5. The SPARTAN trial, published in the New England Journal of Medicine on Feb. 8, found that “median metastasis-free survival was more than 2 years longer” for men who received apalutamide. Read more in the New York Times.

Brendan Curti, M.D., the principal investigator of the new three-arm study at Providence Cancer Institute, is a medical oncologist and director of genitourinary oncology research at the Earle A. Chiles Research Institute.

See Providence study details here:

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

More prostate cancer studies

This study is one of three clinical trials open to men with prostate cancer at Providence Cancer Institute. See all prostate cancer studies.

To refer patients to any of these studies, call Providence Cancer Institute’s Clinical Research office at 503-215-2614 or visit oregon.providence.org/clinical-trials.

Welcome to your journey for creating a healthier you

New apalutamide study opens for prostate cancer

See Providence study details here:

More prostate cancer studies

Previous Article

Next Article

New apalutamide study opens for prostate cancer

See Providence study details here:

More prostate cancer studies

Previous Article

Next Article

Most Recent Articles

When teacher Annie Noguchi suddenly collapsed at home, a team of rescuers acted quickly to save her life.

Mandie Davis’s route to a better life began with a chance meeting with bariatric surgeon Dr. Louise Bacon.

Midwives have the training, skills and knowledge to provide trusted guidance, encouragement and support.

A long-term fitness regimen and deep spiritual belief helped this 82-year-old recover quickly after surgery.

Two heart rhythm specialists talk about what atrial fibrillation is, why it can be dangerous and what your treatment options are.

Stephanie Koutzoukis faced a tough recovery after her tongue cancer returned, but today, thanks to world-class care, she is back to normal.

Stroke expert Dr. Basit Rahim talks about how to spot this potentially deadly health emergency, what to do and how you can reduce your risk.

While the program treats a range of psychiatric conditions, the most common are major depression, anxiety, bipolar disorder, post-traumatic stress disorder (PTSD) and schizophrenia.

Have a fun-filled, healthy summer with these suggestions.

Portland painter credits the support of Providence providers and creating art for helping her recover and heal from breast cancer and the loss of her mother.

Together, Oregon’s hospitals took home 19 awards in the nation’s premier recognition program for environmental performance in health care.

As a health care organization founded by incredibly strong women, Providence’s history is proudly steeped in the traditions of our foundresses, the sisters of St. Joseph and the sisters of Providence.

Growing the Providence Swedish comprehensive women’s health care program in the South Puget Sound, to bring the highest level of specialty services for women in our community.

Attend a FREE lecture at QVMC on June 29, 2023 at 6 p.m.

Hospital receives two national awards for commitment to best practices

Providence medical experts offer the most updated information about research and treatment options for breast and pancreatic cancer patients in two free virtual talks for patients and caregivers.

Attend a FREE live virtual lecture on spine care from our experts on June 22, 2023 at 5:30 p.m.

This marks the fourth time in five years that Providence Holy Cross is honored with this recognition.